Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Wanchain (WAN) Price & Performance

InjectiveTrade
WanchainTrade

Price performance (Past 24H)

Key statistics

Injective vs Wanchain — how do they compare? Injective trades at Rp92,347 (market cap Rp9,23T, Rp1,78T 24h volume), while Wanchain trades at Rp942.12 (market cap Rp240,51M, Rp39,98M 24h volume). The key difference: Injective is far larger — about 38376.8× Wanchain's market cap, and Wanchain's supply is capped (198,9M / 210M WAN (95%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Wanchain for 25 Days on average.

INJWAN
Market Cap
Rp9,23TRp240,51M
Volume (24h)
Rp1,78TRp39,98M
Circulating Supply
100M INJ198,9M / 210M WAN (95%)
Typical Hold Time
36 Days25 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Wanchain

Wanchain currently holds a market cap of Rp240.51 million with 95% of its max supply in circulation. The token exhibits moderate network activity with an average hold time of 25 days, suggesting steady but cautious holder behavior. No recent protocol upgrades or major ecosystem developments have been reported, keeping the project in a stable yet quiet phase.

The outlook remains neutral with limited volatility and adoption growth. Key opportunities include potential future interoperability developments, while risks involve low liquidity and regulatory uncertainty common to smaller cap cryptocurrencies. Investors should monitor for any upcoming network updates or exchange listings that could impact value.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
WAN

No sentiment data available yet.

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Wanchain

WAN is the native cryptocurrency of the Wanchain Layer 1 blockchain, used for transactions and smart contract execution. A portion of WAN is burned with each transaction. The total supply is capped at 210,000,000.

Read more on WAN